Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia.

Langereis JD, Jacobs JFM, de Jonge MI, van Deuren M.

J Transl Med. 2019 May 23;17(1):174. doi: 10.1186/s12967-019-1928-x.

2.

Serum IgM and C-reactive protein binding to phosphorylcholine of non-typeable Haemophilus influenzae increases complement-mediated killing.

Langereis JD, van der Pasch ES, de Jonge MI.

Infect Immun. 2019 May 20. pii: IAI.00299-19. doi: 10.1128/IAI.00299-19. [Epub ahead of print]

PMID:
31109949
3.

Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Oerlemans MMP, Moons SJ, Heming JJA, Boltje TJ, de Jonge MI, Langereis JD.

Infect Immun. 2019 May 21;87(6). pii: e00077-19. doi: 10.1128/IAI.00077-19. Print 2019 Jun.

PMID:
30936154
4.

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.

Ngocho JS, Magoma B, Olomi GA, Mahande MJ, Msuya SE, de Jonge MI, Mmbaga BT.

PLoS One. 2019 Feb 19;14(2):e0212295. doi: 10.1371/journal.pone.0212295. eCollection 2019.

5.

Modifiable risk factors for community-acquired pneumonia in children under 5 years of age in resource-poor settings: a case-control study.

Ngocho JS, de Jonge MI, Minja L, Olomi GA, Mahande MJ, Msuya SE, Mmbaga BT.

Trop Med Int Health. 2019 Apr;24(4):484-492. doi: 10.1111/tmi.13211. Epub 2019 Mar 4.

PMID:
30702791
6.
7.

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.

Voß F, Kohler TP, Meyer T, Abdullah MR, van Opzeeland FJ, Saleh M, Michalik S, van Selm S, Schmidt F, de Jonge MI, Hammerschmidt S.

Front Immunol. 2018 Oct 18;9:2405. doi: 10.3389/fimmu.2018.02405. eCollection 2018.

8.

Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections.

Langereis JD, van der Flier M, de Jonge MI.

Front Immunol. 2018 Aug 23;9:1925. doi: 10.3389/fimmu.2018.01925. eCollection 2018. Review.

9.

Desialylation of Platelets by Pneumococcal Neuraminidase A Induces ADP-Dependent Platelet Hyperreactivity.

Kullaya V, de Jonge MI, Langereis JD, van der Gaast-de Jongh CE, Büll C, Adema GJ, Lefeber D, Cremers AJ, Mmbaga BT, de Groot PG, de Mast Q, van der Ven AJ.

Infect Immun. 2018 Sep 21;86(10). pii: e00213-18. doi: 10.1128/IAI.00213-18. Print 2018 Oct.

10.

Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance.

Heise T, Langereis JD, Rossing E, de Jonge MI, Adema GJ, Büll C, Boltje TJ.

Cell Chem Biol. 2018 Oct 18;25(10):1279-1285.e8. doi: 10.1016/j.chembiol.2018.05.018. Epub 2018 Jul 5.

PMID:
29983272
11.

The endotoxin-induced pulmonary inflammatory response is enhanced during the acute phase of influenza infection.

Koch RM, Diavatopoulos DA, Ferwerda G, Pickkers P, de Jonge MI, Kox M.

Intensive Care Med Exp. 2018 Jul 5;6(1):15. doi: 10.1186/s40635-018-0182-5.

12.

Selective counting and sizing of single virus particles using fluorescent aptamer-based nanoparticle tracking analysis.

Szakács Z, Mészáros T, de Jonge MI, Gyurcsányi RE.

Nanoscale. 2018 Aug 7;10(29):13942-13948. doi: 10.1039/c8nr01310a. Epub 2018 May 30.

PMID:
29845157
13.

The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease.

Cremers AJH, Mobegi FM, van der Gaast-de Jongh C, van Weert M, van Opzeeland FJ, Vehkala M, Knol MJ, Bootsma HJ, Välimäki N, Croucher NJ, Meis JF, Bentley S, van Hijum SAFT, Corander J, Zomer AL, Ferwerda G, de Jonge MI.

Clin Infect Dis. 2019 Jan 1;68(1):61-69. doi: 10.1093/cid/ciy417.

PMID:
29788414
14.

Adaptation of Bordetella pertussis to the Respiratory Tract.

van Beek LF, de Gouw D, Eleveld MJ, Bootsma HJ, de Jonge MI, Mooi FR, Zomer A, Diavatopoulos DA.

J Infect Dis. 2018 May 25;217(12):1987-1996. doi: 10.1093/infdis/jiy125.

PMID:
29528444
15.

For the greater good: Programmed cell death in bacterial communities.

Peeters SH, de Jonge MI.

Microbiol Res. 2018 Mar;207:161-169. doi: 10.1016/j.micres.2017.11.016. Epub 2017 Dec 1. Review.

16.

Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans.

Koch RM, Kox M, van den Kieboom C, Ferwerda G, Gerretsen J, Ten Bruggencate S, van der Hoeven JG, de Jonge MI, Pickkers P.

PLoS One. 2018 Feb 15;13(2):e0191937. doi: 10.1371/journal.pone.0191937. eCollection 2018.

17.

Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.

van den Berg van Saparoea HB, Houben D, de Jonge MI, Jong WSP, Luirink J.

Appl Environ Microbiol. 2018 Apr 2;84(8). pii: e02567-17. doi: 10.1128/AEM.02567-17. Print 2018 Apr 15.

18.

Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

van der Maten E, van den Broek B, de Jonge MI, Rensen KJW, Eleveld MJ, Zomer AL, Cremers AJH, Ferwerda G, de Groot R, Langereis JD, van der Flier M.

Infect Immun. 2018 Mar 22;86(4). pii: e00010-18. doi: 10.1128/IAI.00010-18. Print 2018 Apr.

19.

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.

Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, van der Flier M.

J Clin Immunol. 2018 Feb;38(2):185-192. doi: 10.1007/s10875-017-0474-7. Epub 2018 Jan 15.

20.

Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.

Ederveen THA, Ferwerda G, Ahout IM, Vissers M, de Groot R, Boekhorst J, Timmerman HM, Huynen MA, van Hijum SAFT, de Jonge MI.

Microbiome. 2018 Jan 11;6(1):10. doi: 10.1186/s40168-017-0395-y.

21.

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo.

Koch RM, Kox M, Thijs EJM, Rahamat-Langendoen JC, van de Veerdonk FL, Gerretsen J, Schloesser J, Diavatopoulos D, Rimmelzwaan GF, Netea MG, van der Hoeven JG, de Jonge MI, Pickkers P.

Front Immunol. 2017 Dec 11;8:1600. doi: 10.3389/fimmu.2017.01600. eCollection 2017.

22.

Siglec-1 inhibits RSV-induced interferon gamma production by adult T cells in contrast to newborn T cells.

Jans J, Unger WWJ, Vissers M, Ahout IML, Schreurs I, Wickenhagen A, de Groot R, de Jonge MI, Ferwerda G.

Eur J Immunol. 2018 Apr;48(4):621-631. doi: 10.1002/eji.201747161. Epub 2018 Jan 18.

23.

Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice.

Fransen F, van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, Faas MM, de Vos P.

Front Immunol. 2017 Nov 2;8:1385. doi: 10.3389/fimmu.2017.01385. eCollection 2017.

24.

Spleen-derived IFN-γ induces generation of PD-L1+-suppressive neutrophils during endotoxemia.

Langereis JD, Pickkers P, de Kleijn S, Gerretsen J, de Jonge MI, Kox M.

J Leukoc Biol. 2017 Dec;102(6):1401-1409. doi: 10.1189/jlb.3A0217-051RR. Epub 2017 Oct 3.

PMID:
28974543
25.

Genetic background impacts vaccine-induced reduction of pneumococcal colonization.

Kuipers K, van Selm S, van Opzeeland F, Langereis JD, Verhagen LM, Diavatopoulos DA, de Jonge MI.

Vaccine. 2017 Sep 18;35(39):5235-5241. doi: 10.1016/j.vaccine.2017.08.023. Epub 2017 Aug 17.

26.

Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro.

Kullaya VI, de Mast Q, van der Ven A, elMoussaoui H, Kibiki G, Simonetti E, de Jonge MI, Ferwerda G.

Viral Immunol. 2017 Oct;30(8):576-581. doi: 10.1089/vim.2016.0161. Epub 2017 Aug 7.

PMID:
28783457
27.

Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.

Kuipers K, Jong WSP, van der Gaast-de Jongh CE, Houben D, van Opzeeland F, Simonetti E, van Selm S, de Groot R, Koenders MI, Azarian T, Pupo E, van der Ley P, Langereis JD, Zomer A, Luirink J, de Jonge MI.

Infect Immun. 2017 Sep 20;85(10). pii: e00281-17. doi: 10.1128/IAI.00281-17. Print 2017 Oct.

28.

The Impact of Gut Microbiota on Gender-Specific Differences in Immunity.

Fransen F, van Beek AA, Borghuis T, Meijer B, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HF, de Jonge MI, Faas MM, Boekschoten MV, Smidt H, El Aidy S, de Vos P.

Front Immunol. 2017 Jun 30;8:754. doi: 10.3389/fimmu.2017.00754. eCollection 2017.

29.

Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction.

Heise T, Büll C, Beurskens DM, Rossing E, de Jonge MI, Adema GJ, Boltje TJ, Langereis JD.

Bioconjug Chem. 2017 Jul 19;28(7):1811-1815. doi: 10.1021/acs.bioconjchem.7b00224. Epub 2017 Jun 27.

30.

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

Wimmers F, de Haas N, Scholzen A, Schreibelt G, Simonetti E, Eleveld MJ, Brouwers HM, Beldhuis-Valkis M, Joosten I, de Jonge MI, Gerritsen WR, de Vries IJ, Diavatopoulos DA, Jacobs JF.

Sci Rep. 2017 Mar 7;7:43486. doi: 10.1038/srep43486.

31.

Non-encapsulated Streptococcus pneumoniae, vaccination as a measure to interfere with horizontal gene transfer.

Langereis JD, de Jonge MI.

Virulence. 2017 Aug 18;8(6):637-639. doi: 10.1080/21505594.2017.1309492. Epub 2017 Mar 22. No abstract available.

32.

A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination.

Habets MN, van Selm S, van der Gaast-de Jongh CE, Diavatopoulos DA, de Jonge MI.

PLoS One. 2017 Mar 13;12(3):e0170884. doi: 10.1371/journal.pone.0170884. eCollection 2017.

33.

β2→1-Fructans Modulate the Immune System In Vivo in a Microbiota-Dependent and -Independent Fashion.

Fransen F, Sahasrabudhe NM, Elderman M, Bosveld M, El Aidy S, Hugenholtz F, Borghuis T, Kousemaker B, Winkel S, van der Gaast-de Jongh C, de Jonge MI, Boekschoten MV, Smidt H, Schols HA, de Vos P.

Front Immunol. 2017 Feb 16;8:154. doi: 10.3389/fimmu.2017.00154. eCollection 2017.

34.

Deciphering the distance to antibiotic resistance for the pneumococcus using genome sequencing data.

Mobegi FM, Cremers AJ, de Jonge MI, Bentley SD, van Hijum SA, Zomer A.

Sci Rep. 2017 Feb 16;7:42808. doi: 10.1038/srep42808.

35.

A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.

van der Maten E, de Jonge MI, de Groot R, van der Flier M, Langereis JD.

Sci Rep. 2017 Feb 8;7:42137. doi: 10.1038/srep42137.

36.

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.

Jans J, Wicht O, Widjaja I, Ahout IM, de Groot R, Guichelaar T, Luytjes W, de Jonge MI, de Haan CA, Ferwerda G.

PLoS One. 2017 Jan 30;12(1):e0170877. doi: 10.1371/journal.pone.0170877. eCollection 2017.

37.

Bacterial Lysis through Interference with Peptidoglycan Synthesis Increases Biofilm Formation by Nontypeable Haemophilus influenzae.

Marti S, Puig C, Merlos A, Viñas M, de Jonge MI, Liñares J, Ardanuy C, Langereis JD.

mSphere. 2017 Jan 18;2(1). pii: e00329-16. doi: 10.1128/mSphere.00329-16. eCollection 2017 Jan-Feb.

38.

Phage-Derived Protein Induces Increased Platelet Activation and Is Associated with Mortality in Patients with Invasive Pneumococcal Disease.

Tunjungputri RN, Mobegi FM, Cremers AJ, van der Gaast-de Jongh CE, Ferwerda G, Meis JF, Roeleveld N, Bentley SD, Pastura AS, van Hijum SA, van der Ven AJ, de Mast Q, Zomer A, de Jonge MI.

MBio. 2017 Jan 17;8(1). pii: e01984-16. doi: 10.1128/mBio.01984-16.

39.

Nasopharyngeal carriage of respiratory pathogens in Warao Amerindians: significant relationship with stunting.

Verhagen LM, Hermsen M, Rivera-Olivero IA, Sisco MC, de Jonge MI, Hermans PW, de Waard JH.

Trop Med Int Health. 2017 Apr;22(4):407-414. doi: 10.1111/tmi.12835. Epub 2017 Feb 9.

40.

Human newborn B cells mount an interferon-α/β receptor-dependent humoral response to respiratory syncytial virus.

Jans J, Pettengill M, Kim D, van der Made C, de Groot R, Henriet S, de Jonge MI, Ferwerda G, Levy O.

J Allergy Clin Immunol. 2017 Jun;139(6):1997-2000.e4. doi: 10.1016/j.jaci.2016.10.032. Epub 2016 Dec 5. No abstract available.

PMID:
27931976
41.

Transcriptome assists prognosis of disease severity in respiratory syncytial virus infected infants.

Jong VL, Ahout IM, van den Ham HJ, Jans J, Zaaraoui-Boutahar F, Zomer A, Simonetti E, Bijl MA, Brand HK, van IJcken WF, de Jonge MI, Fraaij PL, de Groot R, Osterhaus AD, Eijkemans MJ, Ferwerda G, Andeweg AC.

Sci Rep. 2016 Nov 11;6:36603. doi: 10.1038/srep36603.

42.

Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population.

Verhagen LM, Rivera-Olivero IA, Hermsen M, Sisco MC, Maes M, Del Nogal B, Bogaert D, Berbers GA, Hermans PW, de Jonge MI, de Waard JH.

Eur Respir J. 2016 Nov;48(5):1492-1496. doi: 10.1183/13993003.00890-2016. Epub 2016 Aug 18. No abstract available.

43.

Antigen-Independent Restriction of Pneumococcal Density by Mucosal Adjuvant Cholera Toxin Subunit B.

Kuipers K, Diavatopoulos DA, van Opzeeland F, Simonetti E, van den Kieboom CH, Kerstholt M, Borczyk M, van IngenSchenau D, Brandsma ET, Netea MG, de Jonge MI.

J Infect Dis. 2016 Nov 15;214(10):1588-1596. Epub 2016 Apr 24.

PMID:
27112503
44.

Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.

Habets MN, van Selm S, van Opzeeland FJ, Simonetti E, Hermans PWM, de Jonge MI, Diavatopoulos DA.

Vaccine. 2016 Nov 21;34(48):5968-5974. doi: 10.1016/j.vaccine.2016.09.057. Epub 2016 Oct 19.

PMID:
27771185
45.

Alternative pathway regulation by factor H modulates Streptococcus pneumoniae induced proinflammatory cytokine responses by decreasing C5a receptor crosstalk.

van der Maten E, de Bont CM, de Groot R, de Jonge MI, Langereis JD, van der Flier M.

Cytokine. 2016 Dec;88:281-286. doi: 10.1016/j.cyto.2016.09.025. Epub 2016 Oct 6.

46.

Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.

Mitsi E, Roche AM, Reiné J, Zangari T, Owugha JT, Pennington SH, Gritzfeld JF, Wright AD, Collins AM, van Selm S, de Jonge MI, Gordon SB, Weiser JN, Ferreira DM.

Mucosal Immunol. 2017 Mar;10(2):385-394. doi: 10.1038/mi.2016.71. Epub 2016 Aug 31.

47.

Patterns in Bacterial- and Viral-Induced Immunosuppression and Secondary Infections in the ICU.

Koch RM, Kox M, de Jonge MI, van der Hoeven JG, Ferwerda G, Pickkers P.

Shock. 2017 Jan;47(1):5-12. Review.

PMID:
27517143
48.

Effects of serostatus and gender on the HRV-16-induced local immune response.

Koch RM, Kox M, Pickkers P, de Jonge MI; Radboudumc Immunoforce group.

Vaccine. 2016 Jul 29;34(35):4087-4091. doi: 10.1016/j.vaccine.2016.06.076. Epub 2016 Jul 4.

PMID:
27389172
49.

Invasive pneumococcal disease leads to activation and hyperreactivity of platelets.

Tunjungputri RN, de Jonge MI, de Greeff A, van Selm S, Buys H, Harders-Westerveen JF, Stockhofe-Zurwieden N, Urbanus RT, de Groot PG, Smith HE, van der Ven AJ, de Mast Q.

Thromb Res. 2016 Aug;144:123-6. doi: 10.1016/j.thromres.2016.06.016. Epub 2016 Jun 16.

PMID:
27322088
50.

Pneumococcal colonization and invasive disease studied in a porcine model.

de Greeff A, van Selm S, Buys H, Harders-Westerveen JF, Tunjungputri RN, de Mast Q, van der Ven AJ, Stockhofe-Zurwieden N, de Jonge MI, Smith HE.

BMC Microbiol. 2016 Jun 8;16:102. doi: 10.1186/s12866-016-0718-3.

Supplemental Content

Loading ...
Support Center